Combination of anti cd19 antibody with a bcl-2 inhibitor and uses thereof

A combination comprising an antibody specific for CD19 wherein said antibody comprises an HCDR1 region comprising sequence SYVMH (SEQ ID NO:

• 1), an HCDR2 region comprising sequence NPYNDG (SEQ ID NO:
• 2), an HCDR3 region comprising sequence GTYYYGTRVFDY (SEQ ID NO:
• 3), an LCDR1 region comprising sequence RSSKSLQNVNGNTYLY (SEQ ID NO:
• 4), an LCDR2 region comprising sequence RMSNLNS (SEQ ID NO:
• 5), and an LCDR3 region comprising sequence MQHLEYPIT (SEQ ID NO:
• 6) and venetoclax for use in the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.